End Stage Renal Disease Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Treatment Type (Transplant, Dialysis); End User (Research and academic institutes, Hospital and Clinics, Dialysis centers)

Report Code: TIPRE00018794 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming
Covid
MARKET INTRODUCTION

Any disorder causing impaired kidney function that leads to chronic kidney disease and progress over a long period of time resulted into end-stage renal disease (ESRD) in which the kidneys can no longer function on their own. It is also called as kidney failure. Factors contributing to the formation of end stage renal disease are hypertension, diabetes, smoking, and aging. The most common cause is diabetes, whereas hypertension (high blood pressure) is the second most cause of ESRD. The treatment of ESRD or CKD includes kidney transplantation or dialysis to keep patient alive.

MARKET DYNAMICS

End stage renal disease market is driving due to factors such as increasing number of patients suffering from kidney failure and the introduction of technologically advanced products, such as low maintenance dialysis equipment and artificial kidney. However, factor such as delay in the diagnosis of chronic kidney disease is expected to hamper the market growth.

MARKET SCOPE

The End stage renal disease market analysis to 2027 is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of End stage renal disease market with detailed market segmentation by Treatment type, and end user. The End stage renal disease market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in End stage renal disease market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The End stage renal disease market is segmented on the basis of Treatment type, and end user. Based on treatment type, market is segmented as Transplant, and Dialysis. The Dialysis segment is further subsegmented into wearable artificial kidney, hemodialysis, and peritoneal dialysis. Based on end user market can be segmented into Research and academic institutes, Hospital and Clinics, Dialysis centers.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the End stage renal disease market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The End stage renal disease market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting End stage renal disease market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the End stage renal disease market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the End stage renal disease market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as treatment type launches, treatment type approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from End stage renal disease market are anticipated to have lucrative growth opportunities in the future with the rising demand for End stage renal disease in the global market. Below mentioned is the list of few companies engaged in the End stage renal disease market.

The report also includes the profiles of key players in End stage renal disease market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Nipro Corporation
- Fresenius Medical Care
- Baxter International, Inc.
- Medtronic Plc
- B. Braun Melsungen AG
- BD
- Asahi Kasei Medical Co., Ltd.
- Cantel Medical
- Nikkiso Co., Ltd.
- JMS Co. Ltd.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 End Stage Renal Disease Market - By Treatment Type
1.3.2 End Stage Renal Disease Market - By End User
1.3.3 End Stage Renal Disease Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. END STAGE RENAL DISEASE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. END STAGE RENAL DISEASE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. END STAGE RENAL DISEASE MARKET - GLOBAL MARKET ANALYSIS
6.1. END STAGE RENAL DISEASE - GLOBAL MARKET OVERVIEW
6.2. END STAGE RENAL DISEASE - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. END STAGE RENAL DISEASE MARKET - REVENUE AND FORECASTS TO 2027 - TREATMENT TYPE
7.1. OVERVIEW
7.2. TREATMENT TYPE MARKET FORECASTS AND ANALYSIS
7.3. TRANSPLANT
7.3.1. Overview
7.3.2. Transplant Market Forecast and Analysis
7.4. DIALYSIS
7.4.1. Overview
7.4.2. Dialysis Market Forecast and Analysis
7.4.3. Wearable Artificial Kidney Market
7.4.3.1. Overview
7.4.3.2. Wearable Artificial Kidney Market Forecast and Analysis
7.4.4. Hemodialysis Market
7.4.4.1. Overview
7.4.4.2. Hemodialysis Market Forecast and Analysis
7.4.5. Peritoneal Dialysis Market
7.4.5.1. Overview
7.4.5.2. Peritoneal Dialysis Market Forecast and Analysis
8. END STAGE RENAL DISEASE MARKET - REVENUE AND FORECASTS TO 2027 - END USER
8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. RESEARCH AND ACADEMIC INSTITUTES, HOSPITAL AND CLINICS, DIALYSIS CENTRES
8.3.1. Overview
8.3.2. Research and academic institutes, Hospital and Clinics, Dialysis centres Market Forecast and Analysis
9. END STAGE RENAL DISEASE MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America End Stage Renal Disease Market Overview
9.1.2 North America End Stage Renal Disease Market Forecasts and Analysis
9.1.3 North America End Stage Renal Disease Market Forecasts and Analysis - By Treatment Type
9.1.4 North America End Stage Renal Disease Market Forecasts and Analysis - By End User
9.1.5 North America End Stage Renal Disease Market Forecasts and Analysis - By Countries
9.1.5.1 United States End Stage Renal Disease Market
9.1.5.1.1 United States End Stage Renal Disease Market by Treatment Type
9.1.5.1.2 United States End Stage Renal Disease Market by End User
9.1.5.2 Canada End Stage Renal Disease Market
9.1.5.2.1 Canada End Stage Renal Disease Market by Treatment Type
9.1.5.2.2 Canada End Stage Renal Disease Market by End User
9.1.5.3 Mexico End Stage Renal Disease Market
9.1.5.3.1 Mexico End Stage Renal Disease Market by Treatment Type
9.1.5.3.2 Mexico End Stage Renal Disease Market by End User
9.2. EUROPE
9.2.1 Europe End Stage Renal Disease Market Overview
9.2.2 Europe End Stage Renal Disease Market Forecasts and Analysis
9.2.3 Europe End Stage Renal Disease Market Forecasts and Analysis - By Treatment Type
9.2.4 Europe End Stage Renal Disease Market Forecasts and Analysis - By End User
9.2.5 Europe End Stage Renal Disease Market Forecasts and Analysis - By Countries
9.2.5.1 Germany End Stage Renal Disease Market
9.2.5.1.1 Germany End Stage Renal Disease Market by Treatment Type
9.2.5.1.2 Germany End Stage Renal Disease Market by End User
9.2.5.2 France End Stage Renal Disease Market
9.2.5.2.1 France End Stage Renal Disease Market by Treatment Type
9.2.5.2.2 France End Stage Renal Disease Market by End User
9.2.5.3 Italy End Stage Renal Disease Market
9.2.5.3.1 Italy End Stage Renal Disease Market by Treatment Type
9.2.5.3.2 Italy End Stage Renal Disease Market by End User
9.2.5.4 Spain End Stage Renal Disease Market
9.2.5.4.1 Spain End Stage Renal Disease Market by Treatment Type
9.2.5.4.2 Spain End Stage Renal Disease Market by End User
9.2.5.5 United Kingdom End Stage Renal Disease Market
9.2.5.5.1 United Kingdom End Stage Renal Disease Market by Treatment Type
9.2.5.5.2 United Kingdom End Stage Renal Disease Market by End User
9.2.5.6 Rest of Europe End Stage Renal Disease Market
9.2.5.6.1 Rest of Europe End Stage Renal Disease Market by Treatment Type
9.2.5.6.2 Rest of Europe End Stage Renal Disease Market by End User
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific End Stage Renal Disease Market Overview
9.3.2 Asia-Pacific End Stage Renal Disease Market Forecasts and Analysis
9.3.3 Asia-Pacific End Stage Renal Disease Market Forecasts and Analysis - By Treatment Type
9.3.4 Asia-Pacific End Stage Renal Disease Market Forecasts and Analysis - By End User
9.3.5 Asia-Pacific End Stage Renal Disease Market Forecasts and Analysis - By Countries
9.3.5.1 Australia End Stage Renal Disease Market
9.3.5.1.1 Australia End Stage Renal Disease Market by Treatment Type
9.3.5.1.2 Australia End Stage Renal Disease Market by End User
9.3.5.2 China End Stage Renal Disease Market
9.3.5.2.1 China End Stage Renal Disease Market by Treatment Type
9.3.5.2.2 China End Stage Renal Disease Market by End User
9.3.5.3 India End Stage Renal Disease Market
9.3.5.3.1 India End Stage Renal Disease Market by Treatment Type
9.3.5.3.2 India End Stage Renal Disease Market by End User
9.3.5.4 Japan End Stage Renal Disease Market
9.3.5.4.1 Japan End Stage Renal Disease Market by Treatment Type
9.3.5.4.2 Japan End Stage Renal Disease Market by End User
9.3.5.5 South Korea End Stage Renal Disease Market
9.3.5.5.1 South Korea End Stage Renal Disease Market by Treatment Type
9.3.5.5.2 South Korea End Stage Renal Disease Market by End User
9.3.5.6 Rest of Asia-Pacific End Stage Renal Disease Market
9.3.5.6.1 Rest of Asia-Pacific End Stage Renal Disease Market by Treatment Type
9.3.5.6.2 Rest of Asia-Pacific End Stage Renal Disease Market by End User
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa End Stage Renal Disease Market Overview
9.4.2 Middle East and Africa End Stage Renal Disease Market Forecasts and Analysis
9.4.3 Middle East and Africa End Stage Renal Disease Market Forecasts and Analysis - By Treatment Type
9.4.4 Middle East and Africa End Stage Renal Disease Market Forecasts and Analysis - By End User
9.4.5 Middle East and Africa End Stage Renal Disease Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa End Stage Renal Disease Market
9.4.5.1.1 South Africa End Stage Renal Disease Market by Treatment Type
9.4.5.1.2 South Africa End Stage Renal Disease Market by End User
9.4.5.2 Saudi Arabia End Stage Renal Disease Market
9.4.5.2.1 Saudi Arabia End Stage Renal Disease Market by Treatment Type
9.4.5.2.2 Saudi Arabia End Stage Renal Disease Market by End User
9.4.5.3 U.A.E End Stage Renal Disease Market
9.4.5.3.1 U.A.E End Stage Renal Disease Market by Treatment Type
9.4.5.3.2 U.A.E End Stage Renal Disease Market by End User
9.4.5.4 Rest of Middle East and Africa End Stage Renal Disease Market
9.4.5.4.1 Rest of Middle East and Africa End Stage Renal Disease Market by Treatment Type
9.4.5.4.2 Rest of Middle East and Africa End Stage Renal Disease Market by End User
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America End Stage Renal Disease Market Overview
9.5.2 South and Central America End Stage Renal Disease Market Forecasts and Analysis
9.5.3 South and Central America End Stage Renal Disease Market Forecasts and Analysis - By Treatment Type
9.5.4 South and Central America End Stage Renal Disease Market Forecasts and Analysis - By End User
9.5.5 South and Central America End Stage Renal Disease Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil End Stage Renal Disease Market
9.5.5.1.1 Brazil End Stage Renal Disease Market by Treatment Type
9.5.5.1.2 Brazil End Stage Renal Disease Market by End User
9.5.5.2 Argentina End Stage Renal Disease Market
9.5.5.2.1 Argentina End Stage Renal Disease Market by Treatment Type
9.5.5.2.2 Argentina End Stage Renal Disease Market by End User
9.5.5.3 Rest of South and Central America End Stage Renal Disease Market
9.5.5.3.1 Rest of South and Central America End Stage Renal Disease Market by Treatment Type
9.5.5.3.2 Rest of South and Central America End Stage Renal Disease Market by End User
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL END STAGE RENAL DISEASE MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. END STAGE RENAL DISEASE MARKET, KEY COMPANY PROFILES
12.1. NIPRO CORPORATION
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. FRESENIUS MEDICAL CARE
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. BAXTER INTERNATIONAL, INC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. MEDTRONIC PLC.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. B. BRAUN MELSUNGEN AG
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. BD
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. ASAHI KASEI MEDICAL CO., LTD.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. CANTEL MEDICAL
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. NIKKISO CO., LTD.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. JMS CO. LTD.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Nipro Corporation
2. Fresenius Medical Care
3. Baxter International, Inc.
4. Medtronic Plc
5. B. Braun Melsungen AG
6. BD
7. Asahi Kasei Medical Co., Ltd.
8. Cantel Medical
9. Nikkiso Co., Ltd.
10. JMS Co. Ltd.
TIPRE00018794
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking